Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Altis Labs, a Toronto-based computational imaging company, is seeking an entrepreneurial Head of Business Development (Biopharma) to lead our commercial efforts and report to the CEO. You will own top biopharma relationships, drive new business across trials, and build scalable sales infra, collaborating with scientific and product leaders to align evidence generation with the roadmap.
This full-cycle, IC role begins solo with potential to scale the sales organization as we grow with large
We build AI models to enable smaller, faster, and more successful clinical trials.
Altis Labs is a computational imaging company focused on improving how oncology trials measure treatment benefit. Our core technology is IPRO, an AI model that generates patient-level outcome predictions directly from routine medical imaging data. Our global biopharma customers use IPRO to predict efficacy, navigate billion-dollar development decisions with confidence, and move their most promising therapies through Phase I–III trials faster. IPRO is trained on the industry’s largest real-world imaging, clinical, and outcomes database, containing over 210 million longitudinal images and more than one million patient-years of linked outcomes.
Our multidisciplinary team of AI scientists, clinicians, and business operators is on a mission to get the most effective treatments to patients sooner. We collaborate closely with academic medical centers and co-publish our results at top-tier medical conferences.
Altis is headquartered in Toronto, serves 6 of the top 20 global biopharmaceutical companies, and is backed by leading life sciences and technology investors.
Altis is looking for an entrepreneurial Head of Business Development (Biopharma) to serve as our commercial leader on our executive team, while reporting to the CEO. You will manage existing Top 10 biopharma relationships and drive new business across large, mid-market, and emerging biotech accounts running Phase 1-3 oncology trials. This is a full sales-cycle, individual-contributor role to start: you’ll own everything from outreach and conference networking through contract close and expansion, while also building the infrastructure that lets us scale and enable you to build the company’s sales organization over time.
The compensation range for this role is $250,000 - $350,000 USD annually, plus equity and benefits. Final offer will reflect experience and qualifications.